Acceptability of Multiparticulate Dosing Using Sympfiny^® Delivery System with Children (Age 1–12)

This study investigated multiparticulate formulation administered over a two-week period of time via the Sympfiny^® system with children of ages 1–12 years. The study was conducted with parent–child pairs (N = 120 total participants) following a specific dose strategy to mimic PURIXAN’s do...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Kate Abeln, Kate Cox, Laura Haggerty, Mary Beth Privitera
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2022-11-01
Edice:	Pharmaceutics
Témata:	multiparticulate acceptability pediatric formulation palatability oral syringe administration device
On-line přístup:	https://www.mdpi.com/1999-4923/14/11/2524
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!